SIROCTID

This brand name is authorized in Austria, France, Italy, Netherlands

Active ingredients

The drug SIROCTID contains one active pharmaceutical ingredient (API):

1 Octreotide UNII RWM8CCW8GP - OCTREOTIDE

Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system. Read about Octreotide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CB02	Octreotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 61426655, 65490897, 66565153
Country: IT	Agenzia del Farmaco	Identifier(s): 039101011, 039101047, 039101074
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 122890, 122904, 122912